(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes were little changed on Monday. The Dow Jones industrial average was down 0.15 percent at 17,576.1, the S&P 500 was down 0.21 percent at 2,045.25 and the Nasdaq Composite was down 0.12 percent at 4,789.91.
** VALSPAR CORP, $104.46, +24.61 pct
** SHERWIN-WILLIAMS CO, $275.61, -4.53 pct
Valspar’s shares are set to open at a record high after rival Sherwin-Williams said on Sunday it would acquire the paint maker in an all-cash deal valued at about $9.3 bln, or $113 per share.
** STARWOOD HOTELS AND RESORTS WORLDWIDE INC, $83.88, +4.11 pct
** MARRIOTT INTERNATIONAL INC, $72.295, -1.18 pct
Marriott said it made a higher offer for Starwood that was accepted by the owner of the Sheraton and Westin hotel brands.
** VALEANT PHARMACEUTICALS INTERNATIONAL INC, $30.28, +12.23 pct
The embattled Canadian drugmaker said Chief Executive Michael Pearson would step down and that the company had appointed activist investor William Ackman to its board.
** IHS INC, $117.92, +6.51 pct
** MARKIT LTD, $32.295, +9.51 pct
U.S. business research provider IHS said it would buy Markit in an all-stock deal valuing the London-based financial data company at about $5.9 billion.
** INTEL CORP, $32.08, -1.84 pct
Sanford C. Bernstein cuts the world’s largest chipmaker’s rating to “underperform” from “market perform” and price target to $26 from $29; Deutsche Bank trims to $37 from $38.
** NEW YORK MORTGAGE TRUST INC, $5.0301, +7.71 pct
The mortgage REIT declared a regular quarterly dividend of 24 cents per share in cash for the quarter ending March 31
** BIOMARIN PHARMACEUTICAL INC, $78.18, -3.41 pct
BioMarin’s drug met the main goal of reducing a toxic buildup of an amino acid in the blood of patients with a genetic disorder, but did not show benefit in related inattention and mood complications.
** AFFYMETRIX INC, $14.4, -9.94 pct
** THERMO FISHER SCIENTIFIC INC, $140, +0.00 pct
Affymetrix, a DNA-based test maker, rejected a $1.5 billion bid by Origin Technologies Corp, supporting the $1.3 bln Thermo Fisher merger deal. (Compiled by Yashaswini Swamynathan in Bengaluru; Edited by Don Sebastian)